Search Results

Best Diet Pills That Work Fast

Wednesday, October 13th, 2010

Reviews of Best Diet Pills That WorkAmong thousands or even tens of thousands of diet pills that you can buy, how can you select the right diet pills that work in your case? You can devote hours and hours browsing the web to find diet pill reviews, only to get contradictory advice. Or you could turn to Lose25Pounds.net for trusted advice and reviews of the best diet pills that work for you. Our goal is to find the very best diet pills on offer and give you unbiased in-depth reviews to help you make the right decision. What is the best diet pill? Which diet pills work? Those are questions that we try to answer. We have reviewed over 200 diet pills and taken the confusion out of the shopping experience by narrowing your search to the elite products in the industry.

Use The Scarsdale Diet To Lose Weight The Healthy Way

Thursday, December 16th, 2010

Scarsdale DietThe Scarsdale diet plan might actually be a healthy option, since you are not required to have the binge eating soups or even survive on lemonade and maple syrup. In contrast, this diet focus on the eating of vegetables, fruits and lean protein sources, whilst restricting calorie intake.

The diet guarantees that you’re going to lose one pound daily by just eating those food items. Additionally, this diet also supports the usage of natural appetite suppressants, artificial sweeteners, vegetables and fruits rich in fiber, lean beef, broiled chicken with no skin and fish.

Here is a diet combination:

Orexigen to U.S. panel: diet pill safe for approval (Reuters)

Saturday, July 19th, 2014

WASHINGTON (Reuters) – Orexigen Therapeutics Inc’s Contrave, the last of a trio of new weight-loss drugs, can effectively help patients shed pounds, the biotech company told a panel of U.S. medical advisers on Tuesday at a meeting set to focus on heart risks.

Company officials are facing a Food and Drug Administration panel of outside advisers who have already rejected two competing diet drugs this year and are likely to have tough questions about the pill’s effect on blood pressure and pulse rates, among other safety concerns.

Low-fat diet may not increase diabetes risks (Reuters)

Monday, February 3rd, 2014

NEW YORK (Reuters Health) – While the low-fat diet craze led some doctors to worry that Americans would instead start eating too many carbohydrates, a new study suggests that eating low-fat doesn’t have to increase carbohydrate-fueled health risks.

Instead, if extra carbohydrates are part of a diet plan that includes more fruits, vegetables, and whole grains, the risk of diabetes – the biggest related health concern — could actually drop, at least in older women, according to the findings.

However, a low-fat, high-carbohydrate diet could create problems in people who already have diabetes, researchers caution.

FDA scrutinizes weight loss pill from Orexigen (AP)

Tuesday, February 18th, 2014

WASHINGTON – Scientists for the Food and Drug Administration said Friday a pill to treat obesity from Orexigen Therapeutics Inc. helped patients lose weight, though it didn’t meet all the criteria set forth by the agency.

The FDA’s review, posted online Friday, also raised questions about the pill’s effects on the heart, a perennial issue for weight loss drugs that have been plagued by safety issues.

Orexigen’s pill Contrave is the third weight loss pill to be reviewed by the FDA this year. FDA officials have acknowledged the need for new weight loss drugs amid an epidemic of U.S. obesity, though the agency rejected the two other medications due to safety concerns.

FDA review scrutinizes weight loss with Orexigen Therapeutic’s obesity pill Contrave

Sunday, June 8th, 2014
WASHINGTON (AP) — Scientists for the Food and Drug Administration said Friday a pill to treat obesity from Orexigen Therapeutics Inc. helped patients lose weight, though it didn’t meet all the criterion set forth by the agency.

The FDA’s review, posted online Friday, also raised questions about the pill’s effects on the heart, a perennial issue for weight loss drugs that have been plagued by safety issues.

Orexigen’s pill Contrave is the third weight loss pill to be reviewed by the FDA this year. FDA officials have acknowledged the need for new weight loss drugs amid an epidemic of U.S. obesity, though the agency rejected the two other medications due to safety concerns.

Which Low Carb Diet Plan Really Works?

Sunday, January 2nd, 2011

Low Carb Diet PlanIf you are looking for that one ultimate low carb diet plan, then you are definitely not alone. Just take a look online, there are hundreds if not thousands of low carb diet plans, all touting that they are the best. Picking just one to follow is hard.  If you are looking for a more natural diet plan then you may have considered using a low carb diet plan, but how effective are they? Keep reading to find out.

New Diet Pill Wins FDA Panel’s Backing (HealthDay)

Wednesday, May 7th, 2014

TUESDAY, Dec. 7 (HealthDay News) — An expert advisory panel recommended on Tuesday that Contrave, a new weight-loss pill that combines an antidepressant with an anti-addiction medication, be approved by the U.S. Food and Drug Administration.

The 13-7 vote in favor of Contrave came amid agency concerns that the drug might raise blood pressure in some patients and increase the risk of heart attacks and strokes among some users, according to the Associated Press. But panelists voted 11-8 earlier in the day that those potential health risks could be studied after Contrave was approved.

U.S. advisers back first new diet pill in a decade (Reuters)

Wednesday, November 27th, 2013

SILVER SPRING, Maryland (Reuters) – The first new weight-loss pill in a decade moved closer to U.S. approval on Tuesday, when a panel of expert advisers backed Orexigen Therapeutics’s Contrave despite heart risk concerns.

It was the third new weight-loss drug to come before U.S. regulators this year, the Food and Drug Administration having rejected two rival medicines in October.

Orexigen’s stock more than doubled to $12.20 from Monday’s close of $4.76 when it reopened in after-hours trade Tuesday. Shares of competitors Vivus Inc and Arena Pharmaceuticals Inc also rose, as investors bet Contrave’s approval could revive their fortunes.

New Diet Pill Wins FDA Panel’s Backing (HealthDay)

Saturday, July 19th, 2014

TUESDAY, Dec. 7 (HealthDay News) — An expert advisory panel recommended on Tuesday that Contrave, a new weight-loss pill that combines an antidepressant with an anti-addiction medication, be approved by the U.S. Food and Drug Administration.

The 13-7 vote in favor of Contrave came amid agency concerns that the drug might raise blood pressure in some patients and increase the risk of heart attacks and strokes among some users, according to the Associated Press. But panelists voted 11-8 earlier in the day that those potential health risks could be studied after Contrave was approved.